CORE--TRANSGENIC AND GENE DISRUPTION LABORATORY

$241,412P01FY2001CANIH

St. Jude Children'S Research Hospital, Memphis TN

Investigators

Linked publications & trials

Paper 27125728 Paper 26578620 Paper 25309971 Paper 24684846 Paper 21358637 Paper 21115501 Paper 20981007 Paper 20484036 Paper 19250909 Paper 19029828 Paper 18652489 Paper 18573879 Paper 18318429 Paper 17761949 Paper 17597811 Paper 17374815 Paper 17287518 Paper 17234769 Paper 17124053 Paper 17124049 Paper 17099725 Paper 17074738 Paper 16917005 Paper 16888896 Paper 16869746 Paper 16750598 Paper 16732579 Paper 16707427 Paper 16618932 Paper 16574405 Paper 16550535 Paper 16436596 Paper 16399862 Paper 16197717 Paper 16157701 Paper 16107711 Paper 16033918 Paper 15853303 Paper 15747338 Paper 15672607 Paper 15643668 Paper 15630450 Paper 15561680 Paper 15546904 Paper 15364174 Paper 15361859 Paper 15358560 Paper 15297309 Paper 15289458 Paper 15251979 Paper 15226186 Paper 15107822 Paper 14990639 Paper 14665695 Paper 14630789 Paper 14585359 Paper 14500377 Paper 12730115 Paper 12718877 Paper 12620229 Paper 12615721 Paper 12606579 Paper 12594042 Paper 12573435 Paper 12498712 Paper 12242297 Paper 12140263 Paper 12086889 Paper 12086872 Paper 11997098 Paper 11981001 Paper 11906209 Paper 11861407 Paper 11726927 Paper 11721960 Paper 11604501 Paper 11533236 Paper 11481442 Paper 11438662 Paper 11301318 Paper 11287627 Paper 11105899 Paper 11070161 Paper 10995391 Paper 10898794 Paper 10858442 Paper 10842176 Paper 10827180 Paper 10802708 Paper 10713175 Paper 10594039 Paper 10594034

Abstract

Revised Abstract: The purpose of this core is to provide genetically modified animals, employing transgenic methodologies, for use in Projects 1-4. Mice will be obtained either via DNA infection of fertilized eggs or via injection of embryonic stem cells (ES cells) into blastocysts. The ES-cells carry targeted mutations obtained via homologous recombination. The core receives injection-ready DNA or ES-cells carrying targeted mutations from the different investigators and provide them with transgenic or chimeric mice for further breeding. In addition, the core will coordinate the injections and provide cell lines, guidance, and advice to investigators to ensure efficient generation of the transgenic strains.

View original record on NIH RePORTER →